Fish oil supplementation in pregnancy for preventing allergy in children

The effect of Omega 3 supplementation to pregnant women on the development of allergic diseases in children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/01/023058

Enrollment

800

Registered

2020-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: The fish oil: The fish oil supplements are planned to be issued as Flavored emulsified fish oil supplement/capsules containing purified water, fish oil (derived from deep cold water fis

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women more than 20 weeks of gestation period and willing to participate in study.

Exclusion criteria

Exclusion criteria: pregnant women less than 20 weeks of gestation and not willing to participate in study.

Design outcomes

Primary

Measure	Time frame
Persistent wheeze Description: Age at onset of persistent wheeze diagnosed according to predefined algorithm of recurrent troublesome lung symptoms, response to treatment and relapse after withdrawal of treatment Timepoint: 0-6 months, 1-2 years, 3 year	—

Secondary

Measure	Time frame
Preterm birth Developmental delays Asthma exacerbations Eczema Anthropometric measurements Allergic sensitization Infections Timepoint: 0-6 months, 1-2 years, 3 year	—

Countries

India

Contacts

Public ContactDr Meenu Singh

Postgraduate Institute of Medical Education and Research

meenusingh4@gmail.com

Outcome results